The relevance of advanced glycation end products to eye disease

Chinese Ophthalmic Research

Volumn 26, Issue 4, 2008, Pages 313-316

  Chen, Ying ^a   Du, Zhiyu ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Advanced glycation end products; Age related eye disease; Cornea; Diabetic complication; Lens; Retina; Vitreous

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALDEHYDE; KETONE;

CATARACT; DIABETES MELLITUS; DIABETIC RETINOPATHY; EYE DISEASE; HUMAN; KERATOPATHY; PATHOPHYSIOLOGY; PROTEIN LOCALIZATION; RETINOPATHY; REVIEW; TISSUE DISTRIBUTION; VISUAL ACUITY; VITREOUS DISEASE;

EID: 43449112404     PISSN: 10030808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Péterszegi G, Robert AM, Robert L, et al. The importance of the Maillard reaction in ophthalmology[J]. J Soc Biol,2007,201(2):209-214
2. Huebschmann AG, Regensteiner JG, Vlassara H, et al. Diabetes and advanced glycoxidation end products[J]. Diabetes Care,2006,29(6):1420-1432
3. Pageon H, Bakala H, Monnier VM, et al. Collagen glycation triggers the formation of aged skin in vitro[J]. Eur J Dermatol,2007,17(1):12-20
4. Dukic-Stefanovic S, Gasic-Milenkovic J, Deuther-Conrad W, et al. Signalling pathways involved in retinal endothelial cell proliferation induced by advanced glycation end products: inhibitory effect of gliclazide [J]. Diabetes Obes Metab,2004,6(2):95-103
5. Ishino Y, Yokoi N, Yasuhara T, et al. Investigation of corneal autofluorescenee in diabetic patients[J]. Nippon Ganka Gakkai Zasshi, 2000,104(8):572-576
6. Sato E, Mori F, Igarashi S, et al. Corneal advanced glycation end products increase in patients with proliferative diabetic retinopathy[J]. Diabetes Care,2001,24(3):479-482
7. Kaji Y, Usui T, Oshika T, et al. Advanced glycation end products in diabetic corneas[J]. Invest Ophthalmol Vis Sci,2000,41(2):362-368
8. McDermott AM, Xiao TL, Kern TS, et al. Non-enzymatic glycation in corneas from normal and diabetic donors and its effects on epithelial cell attachment in vitro[J]. Optometry,2003,74(7):443-452
9. Rehany U, Ishii Y, Lahav M, et al. Ultrastructural changes in corneas of diabetic patients: an electron-microscopy study[J]. Cornea,2000,19(4):534-538
10. Kaji Y, Amano S, Usui T, et al. Advanced glycation end products in Descemet's membrane and their effect on corneal endothelial cell[J]. Curr Eye Res,2001,23(6):469-477
11. Kaji Y, Amano S, Usui T, et al. Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells[J]. Invest Ophthalmol Vis Sci,2003,44(2):521-528
12. Endo M, Yanagisawa K, Tsuchida K, et al. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy[J]. Horm Metab Res,2001,33(5):317-322
13. Zarina S, Zhao HR, Abraham EC. Advanced glycation end products in human senile and diabetic cataractous lenses[J]. Mol Cell Biochem,2000,210(1-2):29-34
14. Franke S, Dawczynski J, Strobel J, et al. Increased levels of advanced glycation end products in human cataractous lenses[J]. J Cataract Refract Surg,2003,29(5):998-1004
15. Kumar MS, Reddy PY, Kumar PA, et al. Effect of dicarbonyl-induced browning on alpha-crystallin chaperone-like activity: physiological significance and caveats of in vitro aggregation assays[J]. Biochem J, 2004,379(Pt 2):273-282
16. Yan H, Willis AC, Harding JJ. Gamma III-crystallin is the primary target of glycation in the bovine lens incubated under physiological conditions [J]. Biochem J,2003,374(Pt 3):677-685
17. Ranjan M, Nayak S, Rao BS. Immunochemical detection of glycated beta-and gamma-crystallins in lens and their circulating autoantibodies (IgG) in streptozocin induced diabetic rat[J]. Mol Vis,2006,13(12):1077-1085
18. Matsumoto Y, Takahashi M, Chikuda M, et al. Levels of mature cross-links and advanced glycation end product cross-links in human vitreous [J]. Jpn J Ophthalmol,2002,46(5):510-517
19. Deguine V, Menasche M, Ferrari P, et al. Free radical depolymerization of hyaluronan by Maillard reaction products: role in liquefaction of aging vitreous[J]. Int J Biol Macromol,1998,22(1):17-22
20. Katsumura C, Sugiyama T, Nakamura K, et al. Effects of advanced glycation end products on hyaluronan photolysis: a new mechanism of diabetic vitreopathy[J]. Ophthalmic Res,2004,36(6):327-331
21. Stitt AW, Bhaduri T, McMullen CB, et al. Advanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic rats [J]. Mol Cell Biol Res Commun,2000,3(6):380-388
22. Moore TC, Moore JE, Kaji Y, et al. The role of advanced glycation end products in retinal microvascular leukostasis[J]. Invest Ophthalmol Vis Sci,2003,44(10):4457-4464
23. Kaji Y, Usui T, Ishida S, et al. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products[J]. Invest Ophthalmol Vis Sci,2007,48(2):858-865
24. Chen BH, Jiang DY, Tang LS. Advanced glycation end-products induce apoptosis involving the signaling pathways of oxidative stress in bovine retinal pericytes[J]. Life Sci,2006,79(11):1040-1048
25. Mamputu JC, Renier G. Advanced glycation end products increase, through a protein kinase C-dependent pathway, vascular endothelial growth factor expression in retinal endothelial cells. Inhibitory effect of gliclazide[J]. J Diab Complicat,2002,16(4):284-293
26. Stitt AW, Hughes SJ, Canning P, et al. Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth faetor[J]. Diabetologia,2004,47(10):1735-1746
27. Kobayashi T, Oku H, Komori A, et al. Advanced glycation end products induce death of retinal neurons via activation of nitric oxide synthase[J]. Exp Eye Res,2005,81(6):647-654
28. Lecleire-Collet A, Tessier LH, Massin P. Advanced glycation end products can induce glial reaction and neuronal degeneration in retinal explants [J]. Br J Ophthalmol,2005,89(12):1631-1633
29. Schutt F, Bergmann M, Holz FG, et al. Proteins modified by malondialdehyde, 4-hydroxynonenal, or advanced glycation end products in lipofuscin of human retinal pigment epithelium[J]. Invest Ophthalmol Vis Sci,2003,44(8):3663-3668
30. Hollyfield JG, Salomon RG, Crabb JW. Proteomic approaches to understanding age-related macular degeneration[J]. Adv Exp Med Biol, 2003,533:83-89
31. Howes KA, Liu Y, Dunaief JL, et al. Receptor for advanced glycation end products and age-related macular degeneration[J]. Invest Ophthalmol Vis Sci,2004,45(10):3713-3720
32. Ma W, Lee SE, Guo J, et al. RAGE ligand upregulation of VEGF secretion in ARPE-19 cells[J]. Invest Ophthalmol Vis Sci,2007,48(3):1355-1361
33. Kobayashi S, Nomura M, Nishioka T, et al. Overproduction of N (epsilon)-(carboxymethyl) lysine-induced neovascularization in cultured choroidal explant of aged rat[J]. Biol Pharm Bull,2007,30(1):133-138